Everpar Advisors LLC Trims Stock Position in Cigna Group $CI

Everpar Advisors LLC trimmed its stake in Cigna Group (NYSE:CIFree Report) by 11.3% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 813 shares of the health services provider’s stock after selling 104 shares during the period. Everpar Advisors LLC’s holdings in Cigna Group were worth $269,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also made changes to their positions in the company. Flaharty Asset Management LLC purchased a new stake in shares of Cigna Group in the 1st quarter valued at approximately $28,000. 1248 Management LLC purchased a new stake in shares of Cigna Group in the 1st quarter valued at approximately $29,000. Activest Wealth Management raised its stake in shares of Cigna Group by 360.0% in the 1st quarter. Activest Wealth Management now owns 92 shares of the health services provider’s stock valued at $30,000 after acquiring an additional 72 shares during the period. Retirement Wealth Solutions LLC raised its stake in shares of Cigna Group by 74.1% in the 2nd quarter. Retirement Wealth Solutions LLC now owns 101 shares of the health services provider’s stock valued at $33,000 after acquiring an additional 43 shares during the period. Finally, Putney Financial Group LLC purchased a new stake in shares of Cigna Group in the 4th quarter valued at approximately $36,000. 86.99% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, insider Nicole S. Jones sold 28,526 shares of the company’s stock in a transaction on Friday, August 15th. The shares were sold at an average price of $300.00, for a total value of $8,557,800.00. Following the completion of the sale, the insider owned 25,648 shares in the company, valued at $7,694,400. This represents a 52.66% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.70% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on CI. Truist Financial set a $375.00 price target on shares of Cigna Group in a research note on Tuesday, September 2nd. Cantor Fitzgerald restated an “overweight” rating and issued a $365.00 price objective on shares of Cigna Group in a report on Tuesday, August 26th. Deutsche Bank Aktiengesellschaft set a $415.00 price objective on shares of Cigna Group and gave the company a “buy” rating in a report on Tuesday, August 5th. Wall Street Zen upgraded shares of Cigna Group from a “hold” rating to a “buy” rating in a report on Saturday. Finally, Royal Bank Of Canada restated an “outperform” rating and issued a $371.00 price objective on shares of Cigna Group in a report on Thursday, June 26th. Two investment analysts have rated the stock with a Strong Buy rating, fourteen have given a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Cigna Group currently has a consensus rating of “Buy” and a consensus price target of $371.81.

Read Our Latest Stock Report on CI

Cigna Group Stock Down 1.1%

Shares of NYSE:CI opened at $293.88 on Wednesday. The company has a market capitalization of $78.45 billion, a PE ratio of 16.04, a P/E/G ratio of 0.87 and a beta of 0.48. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.65. Cigna Group has a twelve month low of $256.89 and a twelve month high of $366.91. The firm has a 50 day simple moving average of $294.79 and a 200-day simple moving average of $311.90.

Cigna Group (NYSE:CIGet Free Report) last issued its quarterly earnings data on Thursday, July 31st. The health services provider reported $7.20 earnings per share for the quarter, topping the consensus estimate of $7.15 by $0.05. The business had revenue of $67.13 billion during the quarter, compared to the consensus estimate of $62.61 billion. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The company’s revenue was up 11.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $6.72 EPS. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, equities analysts predict that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, September 18th. Investors of record on Thursday, September 4th will be given a $1.51 dividend. The ex-dividend date is Thursday, September 4th. This represents a $6.04 annualized dividend and a yield of 2.1%. Cigna Group’s dividend payout ratio is 32.97%.

About Cigna Group

(Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Read More

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.